Search

Results: 1

Cover Image for Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Rosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, Isabella Tosi, Shane Solanky, Chrysanthi Ainali, Zeynep Catak, Hemawtee Sreeneebus, Jake Saklatvala, Nick Dand, Emanuele de Rinaldis, Anna Chapman, Frank O Nestle, Michael R Barnes, Richard B Warren, Nick J Reynolds, Christopher EM Griffiths, Jonathan N Barker, Catherine H Smith, Paola Di Meglio, PSORT Consortium

Sep 08, 2021

Adalimumab B7-H1 Antigen Biological Therapy Biomarkers Dendritic Cells Humans Interleukin-17 Lipopolysaccharides Lymphocytes NF-kappa B Phosphorylation psoriasis Sensitivity and Specificity Signal Transduction Tumor Necrosis Factor Inhibitors Tumor Necrosis Factor-alpha